الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 134 |  |  |
| | | from | 134 | | |
Abstract
Introduction:
Endometriosis is an estrogen-dependent disease affecting up to 10% of women of reproductive age. It is diagnosed in 50% of infertile women with normal ovulation and normospermic parteners (Giudice and Kao, 2004; Ilangavan and Kalu, 2010) and in more than 60% of females with chronic pelvic pain. Letrozole is a third-generation aromatase inhibitor, suppressing local and systematical estrogen production, which plays a critical role in the pathogenesis of endometriosis and could be used as a treatment modality to avoid surgery.
Aim of the study:
The aim of this study was to investigate whether letrozole has an inhibitory effect on the growth and angiogenesis of endometriosis in an experimental rat model.
Materials and method:
Twenty female, non-pregnant Wistar albino rats were used to create a model for the experimental induction of endometriosis. Rats were divided into treatment (letrozole) and control groups, endometriosis was surgically induced in rats by transplanting an autologous fragment of endometrial tissue onto the inner surface of the abdominal wall. After 30 days, rats underwent a second laparotomy to examine the endometrial implants for size and viability. The rats in the letrozole group (n =10) received oral letrozole crushed and suspended in normal saline through gastric tube at same time each day for 24 days. Rats in the control group (n =10) were given normal saline by the same route as letrozole group at the end of the treatment period, all rats were euthanized. Measurement of the ectopic endometriosis, Histological and immune-histopathological evaluation were conducted.
Conclusion:
Treatment with letrozole reduced the size of the ectopic endometriosis. In addition, treatment with aromatase inhibitors normalizes the levels of proangiogenic factors eg: VEGF in the lesion.
Recommendation:
Aromatase inhibitors including letrozole could be one of the promising treatment modality for endometriosis. Further investigations are required to pave the way for clinical application.